The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Fried Robert N since 2015.
This trader's CIK number is 1417952.
At the time of last reporting, Fried Robert N was the Chief Executive Officer of Niagen Bioscience, Inc.. (stock ticker symbol NAGE).
Also see all insider trading activities at Niagen Bioscience, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | COGT | 2,000 | $7,500 | 0 | $0 | 0 | $0 |
| 2015 | COGT | 0 | $0 | 0 | $0 | 100,000 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | NAGE | 0 | $0 | 0 | $0 | 20,000 | $52,200 |
| 2025 | NAGE | 0 | $0 | 0 | $0 | 66,667 | $220,001 |
| 2023 | NAGE | 7,000 | $9,940 | 0 | $0 | 0 | $0 |
| 2022 | NAGE | 105,000 | $154,000 | 0 | $0 | 0 | $0 |
| 2021 | NAGE | 10,000 | $66,500 | 0 | $0 | 0 | $0 |
| 2020 | NAGE | 1,000 | $4,690 | 0 | $0 | 0 | $0 |
| 2019 | NAGE | 19,753 | $69,955 | 0 | $0 | 0 | $0 |
| 2017 | NAGE | 10,000 | $31,500 | 0 | $0 | 0 | $0 |
| 2016 | NAGE | 15,000 | $50,850 | 5,063 | $6,379 | 0 | $0 |
2. Niagen Bioscience, Inc. (NAGE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-11-07 | COGT | Buy | 2,000 | 3.75 | 7,500 |
| 2015-09-24 | IDI | Option Ex | 63,000 | .00 | 0 |
| 2015-07-28 | IDI | Option Ex | 37,000 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-04-24 | NAGE | Option Ex | 20,000 | 2.61 | 52,200 |
| 2025-04-09 | NAGE | Option Ex | 66,667 | 3.30 | 220,001 |
| 2023-05-31 | CDXC | Buy | 7,000 | 1.42 | 9,940 |
| 2022-09-30 | CDXC | Buy | 80,000 | 1.25 | 100,000 |
| 2022-03-16 | CDXC | Buy | 25,000 | 2.16 | 54,000 |
| 2021-05-13 | CDXC | Buy | 10,000 | 6.65 | 66,500 |
| 2020-05-19 | CDXC | Buy | 1,000 | 4.69 | 4,690 |
| 2019-11-14 | CDXC | Buy | 10,000 | 3.09 | 30,900 |
| 2019-08-23 | CDXC | Buy | 2,500 | 4.03 | 10,075 |
| 2019-05-21 | CDXC | Buy | 2,253 | 4.43 | 9,980 |
| 2019-03-15 | CDXC | Buy | 5,000 | 3.80 | 19,000 |
| 2017-08-15 | CDXC | Buy | 10,000 | 3.15 | 31,500 |
| 2016-09-01 | CDXC | Buy | 15,000 | 3.39 | 50,850 |
| 2016-01-29 | CDXC.OB | Sale | 5,063 | 1.26 | 6,379 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fried Robert N (Chief Executive Officer of Niagen Bioscience, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.